Ophthalmology Innovation Summit
Ophthalmology Innovation Summit
November 24, 2018
3 min watch

VIDEO: Notal Vision pursues home-based OCT for wet AMD monitoring

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

CHICAGO — At the Ophthalmology Innovation Summit at AAO, Quinton Oswald, CEO of Notal Vision, discusses the company’s pursuit of an OCT home monitoring system for patients with wet age-related macular degeneration, which would help specialists to better tailor treatment to the needs of each patient.